news EC gives verdict on DINP and DIDP
The European Commission (EC) has concluded that the high phthalate plasticizers DINP and DIDP are safe for use in all current consumer applications and that there is an “absence of any further risks”. It published its report on 31
January regarding the re-evaluation of restrictions on DINP and DIDP in toys and childcare articles which can be placed in the mouth. The conclusions are fully aligned
Polimarky plans new investment
Polimarky is increasing compounding capacity at its plant at Głogów Małopolski, near Rzeszów, Poland. The company is investing
€2 million in the facility which it opened in 2009 in the Głogów Małopolski part of the Euro-Park Mielec Special Economic Zone. The new project is expected to be completed in 2015 and will create at least 12 new jobs. Polimarky operates two
production plants – the other is nearby at Rzeszów. It produces a range of compounds for injection moulding and extrusion applications based on PP, PA, POM, PC and various styrenics. It also produces halogen-free fl ame-retar- dant cable compounds and is involved in R&D projects in areas such as polymer nanocomposites.
www.polimarky.pl
8
with the main conclusions presented in August last year by the European Chemicals Agency (ECHA). The EC report states that “no
unacceptable risk has been characterised for the uses of DINP and DIDP in articles other than toys and childcare articles which can be placed in the mouth”. The Commission concluded that “in the light of the absence of any further risks from the uses of DINP and
DIDP, the evaluation of potential substitutes has been less pertinent. DINP and DIDP are therefore safe for use in all current consumer applications”. Dr Stéphane Content, manager of the European Council for Plasticisers and Intermediates (ECPI), said: “DINP and DIDP have proved to be reliable substitutes for the classifi ed low phthalates which are currently undergoing REACH Authorisation”.
Regarding children, the
ECHA concluded that “no further risk management measures are needed to reduce the exposure of children to DINP and DIDP”. In the case of adults, the
biomonitoring data reviewed by ECHA confi rmed that “exposure from food and the indoor environment are not very signifi cant”. The full EC report is at:
http://bit.ly/DIDPDINP
Fainplast invests in new capacity
Italian compounder Fainplast has invested €700,000 to increase production capacity for its Evatech material by 3,500 tonnes/year. Evatech is based on
ethylene-vinyl acetate (EVA) and is formulated to be foamed and cross-linked. The compound is used in the moulding of shoe soles, mid-soles and slippers, as well as packaging and furniture applications. According to Fainplast, the
expanded material provides low density combined with
Fainplast’s new line is producing Evatech compounds
good physical and mechanical properties, including high abrasion resistance and an excellent tactile feel. It can be
supplied a range of hardness levels, densities and colours to meet customer requirements.
www.fainplast.com
Oxea boosts plasticizer production
Oxea has increased capacity for specialty esters by 20% at its Amsterdam plant in the Netherlands. The chemicals are used in the production of several phthalate-free plasticizers at the site, including TOTM and DOTP products marketed under the Oxsoft brand name. The company says that the
COMPOUNDING WORLD | February 2014
capacity upgrade will specifi - cally benefi t producers of medical devices and fl ooring. Jacco de Haas, global
marketing manager for specialty esters at Oxea, said: “At the end of last year a leading fl ooring company announced its decision to switch to phthalate- free products. Shortly after, the main European DOP producer
announced that it would discontinue production of this plasticizer, which is also still widely used in medical applications. Our successful capacity expansion will enable our customers to make a timely switch from DOP to alternative products such as TOTM and DOTP.”
www.oxea-chemicals.com
www.compoundingworld.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66
